Blog – Page 13

This pace of discovery might be expected given the extreme intricacy of the brain and psychiatric disorders.

“The brain is incredibly complex — we’re talking about tens of billions of neurons with trillions of connections,” says Kozo Kaibuchi, director of the International Center for Brain Science (ICBS) at Fujita Health University, near Nagoya in Japan. “Psychiatric and neurological disorders are also highly diverse — often involving subtle changes on a spectrum rather than one obvious cause.”

On top of that, there are further obstacles that hinder progress in developing treatments for these conditions — the difficulty of imaging inside the human brain; the scarcity of human-like models; and the blood–brain barrier, which prevents most drugs from entering the brain.

Newly published research in the peer-reviewed journal Nature Cancer suggests that bacteria inside brain tumors may play a far more active role in how cancers grow, spread and respond to treatment than previously understood, according to Prof. Ravid Straussman of the Weizmann Institute of Science.

For years, scientists considered tumors as places where bacteria didn’t grow.

If this problem persists, please email us at support AT timesofisrael.com.

Be sure to include in your email the following details:

Your IP 2600:3c00::f03c:92ff: fe29:18d2.

Glioblastoma—the most aggressive form of brain cancer—remains one of medicine’s biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after diagnosis.

However, a new discovery might change how doctors understand and monitor this deadly disease. Specifically, the study focused on isocitrate dehydrogenase (IDH) wild-type glioblastoma, the most common and rapidly growing form of the tumor, known for its poor prognosis and limited treatment options.

In a study published in Neuro-Oncology, researchers found that brain regions far away from the tumor—known as the contralateral hemisphere (the side opposite to tumor)—can reveal vital clues about a patient’s survival in IDH wild-type glioblastoma.